These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting. Cooper DK; Good AH; Ye Y; Koren E; Oriol R; Ippolito RM; Malcolm AJ; Neethling FA; Romano E; Zuhdi N Transplant Proc; 1993 Feb; 25(1 Pt 1):377-8. PubMed ID: 8438342 [No Abstract] [Full Text] [Related]
17. Role of adhesion molecules in islet allo- and xenograft rejection. Gotoh M; Ohzato H; Fukuzaki T; Ohta Y; Nishihara M; Hasuike Y; Umeshita K; Sakon M; Yagita H; Okumura K; Miyasaka M; Monden M Transplant Proc; 1996 Apr; 28(2):617. PubMed ID: 8623304 [No Abstract] [Full Text] [Related]
18. Regulation of immune reactivity and tolerance by antigen migration and localization: with particular reference to allo- and xenotransplantation. Starzl TE; Murase N; Thomson AW; Trucco M; Rao A Transplant Proc; 1999; 31(1-2):763-8. PubMed ID: 10083325 [No Abstract] [Full Text] [Related]
19. T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation. Thistlethwaite JR; Buckingham M; Stuart JK; Gaber AO; Mayes JT; Stuart FP Transplant Proc; 1987 Feb; 19(1 Pt 1):722-4. PubMed ID: 3079164 [No Abstract] [Full Text] [Related]
20. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression. Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]